NasdaqGS:CRNXPharmaceuticals
A Look At Crinetics Pharmaceuticals (CRNX) Valuation After Recent Share Price Weakness
Recent Trading Performance for Crinetics Pharmaceuticals (CRNX)
Crinetics Pharmaceuticals (CRNX) has drawn investor attention after a period of weaker share performance, with the stock down about 3% over the past day, 6% over the past week, and 26% year to date.
See our latest analysis for Crinetics Pharmaceuticals.
At a share price of US$34.52, short term momentum has faded, with the stock down over recent weeks. However, the 1 year total shareholder return of 8.3% and 3 year total...